Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma.
The prognosis in patients with pancreatic cancer is poor and some authors describe it as a lethal disease. At the time of diagnosis only 14% of patients could be surgically treated and up to 30% of them die within 12 months. Therefore, further clinical investigations on preoperative patient qualific...
Main Authors: | Ł Duda-Barcik, G Marek, J Słonina, M Sebastian, W Kielan, M Jelen, D Zyśko, P Zukrowski, Z Grzebieniak, A K Agrawal, J Rudnicki |
---|---|
Format: | Article |
Language: | English |
Published: |
Via Medica
2010-08-01
|
Series: | Folia Histochemica et Cytobiologica |
Online Access: | http://czasopisma.viamedica.pl/fhc/article/view/4234 |
Similar Items
-
The importance of preoperative elevated serum levels of CEA and CA15-3 in patients with breast cancer in predicting its histological type.
by: J Słonina, et al.
Published: (2010-06-01) -
Androgen receptors as a prognostic and predictive factor in breast cancer.
by: Jerzy Rudnicki, et al.
Published: (2008-12-01) -
Inhibition of cysteine peptidase activity in ascitic fluid in pancreatic cancer patients.
by: Adam Skalski, et al.
Published: (2011-04-01) -
Molecular markers (c-erbB-2, p53) in breast cancer.
by: Piotr Zukrowski, et al.
Published: (2009-01-01) -
Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
by: Taxiarchis Botsis, et al.
Published: (2010-01-01)